← Open Payments lookup

NICOLE DEBETTENCOURT: Open Payments

NPI 1235471244 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$766 in 30 payments from 12 companies in 2025. Trend: 2023 $257 · 2024 $976 · 2025 $766

Food & beverage: $766
CompanyPaymentsAmount
Madrigal Pharmaceuticals7$160
Ipsen Biopharmaceuticals, Inc5$133
Janssen Biotech, Inc.2$116
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$85
Mallinckrodt Hospital Products Inc.2$63
ORPHALAN INC3$62
Gilead Sciences, Inc.2$33
GENZYME CORPORATION1$29
Takeda Pharmaceuticals U.S.A., Inc.1$28
Novo Nordisk Inc1$21

Products named: REZDIFFRA, IQIRVO, TREMFYA, XIFAXAN, TERLIVAZ, CUVRIOR, DUPIXENT, EOHILIA.

Industry payments across MD — which companies pay providers there.